GLUE · Company research

Monte Rosa Therapeutics, Inc. Common Stock (GLUE): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

21records availableHealthcare

Stock News & Events data

Database-backed records only

21 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
GLUE Dec 2026 15.000 call (GLUE261218C00015000) interactive stock chart - Yahoo Finance UKGLUE Dec 2026 15.000 call (GLUE261218C00015000) interactive stock chart Yahoo Finance UKView source ↗Yahoo Finance UKOct 15, 2026neutral00.6
GLUE Dec 2026 10.000 put (GLUE261218P00010000) stock price, news, quote and history - Yahoo Finance UKGLUE Dec 2026 10.000 put (GLUE261218P00010000) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKOct 15, 2026neutral00.6
GLUE261016C00035000 Interactive Stock Chart | GLUE Oct 2026 35.000 call Stock - Yahoo FinanceGLUE261016C00035000 Interactive Stock Chart | GLUE Oct 2026 35.000 call Stock Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
GLUE Dec 2026 10.000 put (GLUE261218P00010000) Interactive Stock Chart - Yahoo! Finance CanadaGLUE Dec 2026 10.000 put (GLUE261218P00010000) Interactive Stock Chart Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 14, 2026neutral00.6
GLUE261218P00010000 Interactive Stock Chart | GLUE Dec 2026 10.000 put Stock - Yahoo FinanceGLUE261218P00010000 Interactive Stock Chart | GLUE Dec 2026 10.000 put Stock Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
GLUE261016C00010000 Interactive Stock Chart | GLUE Oct 2026 10.000 call Stock - Yahoo FinanceGLUE261016C00010000 Interactive Stock Chart | GLUE Oct 2026 10.000 call Stock Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Rated "Moderate Buy" by Sell-Side Brokerages - MarketBeatMonte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Rated "Moderate Buy" by Sell-Side Brokerages MarketBeatView source ↗MarketBeatOct 13, 2026neutral00.6
Monte Rosa Therapeutics (NASDAQ:GLUE) Shares Up 4.4% - What's Next? - MarketBeatMonte Rosa Therapeutics (NASDAQ:GLUE) Shares Up 4.4% - What's Next? MarketBeatView source ↗MarketBeatOct 7, 2026neutral00.6
Trading the Move, Not the Narrative: (GLUE) Edition - Stock Traders DailyTrading the Move, Not the Narrative: (GLUE) Edition Stock Traders DailyView source ↗Stock Traders DailyOct 7, 2026neutral00.6
Monte Rosa Therapeutics (NASDAQ:GLUE) Coverage Initiated by Analysts at HC Wainwright - MarketBeatMonte Rosa Therapeutics (NASDAQ:GLUE) Coverage Initiated by Analysts at HC Wainwright MarketBeatView source ↗MarketBeatOct 7, 2026neutral00.6
GLUE Oct 2026 12.500 put (GLUE261016P00012500) Stock Price, News, Quote & History - Yahoo! Finance CanadaGLUE Oct 2026 12.500 put (GLUE261016P00012500) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 6, 2026neutral00.6
These Easy Crafts Let Kids Make Their Own Halloween Magic - The Pioneer WomanThese Easy Crafts Let Kids Make Their Own Halloween Magic The Pioneer WomanView source ↗The Pioneer WomanOct 5, 2026neutral00.6
Monte Rosa Therapeutics (NasdaqGS:GLUE) Stock Forecast & Analyst Predictions - Simply Wall StreetMonte Rosa Therapeutics (NasdaqGS:GLUE) Stock Forecast & Analyst Predictions Simply Wall StreetView source ↗Simply Wall StreetOct 5, 2026neutral00.6
Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM) - The Globe and MailAnalysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM) The Globe and MailView source ↗The Globe and MailOct 3, 2026neutral00.6
$GLUE stock is down 8% today. Here's what we see in our data. - Quiver Quantitative$GLUE stock is down 8% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeOct 2, 2026neutral00.6
Monte Rosa Therapeutics Shares Surge Premarket - Monte Rosa Therapeutics (NASDAQ:GLUE) - BenzingaMonte Rosa Therapeutics Shares Surge Premarket - Monte Rosa Therapeutics (NASDAQ:GLUE) BenzingaView source ↗BenzingaOct 1, 2026neutral00.6
Monte Rosa Therapeutics (Nasdaq:GLUE) - Stock Analysis - Simply Wall StreetMonte Rosa Therapeutics (Nasdaq:GLUE) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetOct 1, 2026neutral00.6
Safety and activity data will be presented Oct. 1 for people at elevated heart-disease risk after four weeks of treatment. - Stock TitanSafety and activity data will be presented Oct. 1 for people at elevated heart-disease risk after four weeks of treatment. Stock TitanView source ↗Stock TitanSep 30, 2026neutral00.6
Former glue salesman Sun Aixiang becomes a billionaire as chip stock soars - Billionaires.AfricaFormer glue salesman Sun Aixiang becomes a billionaire as chip stock soars Billionaires.AfricaView source ↗Billionaires.AfricaSep 30, 2026neutral00.6
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? - StocktwitsBIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? StocktwitsView source ↗StocktwitsJul 31, 2026neutral00.6
$GLUE stock is down 31% today. Here's what we see in our data. - Quiver Quantitative$GLUE stock is down 31% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJul 31, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.